DiaMedica Therapeutics, Inc. (DMAC)
7.26
+0.41
(+5.99%)
USD |
NASDAQ |
Sep 21, 16:00
7.26
0.00 (0.00%)
After-Hours: 20:00
DiaMedica Therapeutics Market Cap : 391.50M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 369.39M |
| September 17, 2026 | 369.39M |
| September 16, 2026 | 357.53M |
| September 15, 2026 | 352.13M |
| September 14, 2026 | 353.21M |
| September 11, 2026 | 348.90M |
| September 10, 2026 | 348.90M |
| September 09, 2026 | 355.37M |
| September 08, 2026 | 352.67M |
| September 04, 2026 | 364.00M |
| September 03, 2026 | 353.75M |
| September 02, 2026 | 364.00M |
| September 01, 2026 | 347.82M |
| August 31, 2026 | 342.43M |
| August 28, 2026 | 344.59M |
| August 27, 2026 | 364.00M |
| August 26, 2026 | 361.30M |
| August 25, 2026 | 363.46M |
| August 24, 2026 | 351.60M |
| August 21, 2026 | 351.60M |
| August 20, 2026 | 351.60M |
| August 19, 2026 | 367.23M |
| August 18, 2026 | 356.45M |
| August 17, 2026 | 356.99M |
| August 14, 2026 | 360.22M |
| Date | Value |
|---|---|
| August 13, 2026 | 364.00M |
| August 12, 2026 | 368.85M |
| August 11, 2026 | 370.47M |
| August 10, 2026 | 358.61M |
| August 07, 2026 | 364.00M |
| August 06, 2026 | 365.08M |
| August 05, 2026 | 359.13M |
| August 04, 2026 | 352.40M |
| August 03, 2026 | 351.32M |
| July 31, 2026 | 341.62M |
| July 30, 2026 | 350.78M |
| July 29, 2026 | 340.54M |
| July 28, 2026 | 357.79M |
| July 27, 2026 | 363.17M |
| July 24, 2026 | 362.90M |
| July 23, 2026 | 367.48M |
| July 22, 2026 | 373.68M |
| July 21, 2026 | 381.49M |
| July 20, 2026 | 377.72M |
| July 17, 2026 | 393.35M |
| July 16, 2026 | 384.19M |
| July 15, 2026 | 411.67M |
| July 14, 2026 | 400.35M |
| July 13, 2026 | 403.59M |
| July 10, 2026 | 413.28M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
| Savara, Inc. | 1.120B |
| Vericel Corp. | 2.023B |
Market Cap Related Metrics
| PEG Ratio | -2.962 |
| Price to Book Value | 10.21 |
| Price | 7.26 |
| Earnings Yield | -9.83% |
| PEGY Ratio | -2.962 |